← Leaderboards
Soban Umar
University Of California Los Angeles
$2,400,392
Attributed
$2,400,392
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $556.1K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,400,392 · 2
By mechanism
R01$1,521,272 · 1
K08$879,120 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Mansoureh Eghbali$10,436,797
- Hua Linda Cai$18,515,897
- Srinivasa Reddy$11,348,036
- Anh D Le$4,956,118
- David Abram Zisman$767,837
Others in their field
Other Emerging Leaders on “Transcription Factor”
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
- Adam David Hoppe · South Dakota State University$9,046,059
- Jason Daniel Buenrostro · Broad Institute, Inc.$8,375,564
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,224,019
- Carl Wu · Johns Hopkins University$7,122,467
- Stacy Andersen · Boston Medical Center$7,032,657
Research focus
Transcription FactorSmooth Muscle MyocytesTargeted TreatmentPre-ClinicalPrognostic SignificanceRattusMorbidity - Disease RateMolecularNew Therapeutic TargetPhenotypeIn VivoIn VitroPulmonary HypertensionKnock-DownEndotheliumInsightMediatingMesenchymalInnovationMortalityOverexpressionNovel TherapeuticsInvestigationTranscriptome Sequencing
Grant awards (9)
Investigating the molecular mechanisms of right ventricular failure in pulmonary hypertension$380,318
R01 · FY2025 · HL · contact PI
Investigating the molecular mechanisms of right ventricular failure in pulmonary hypertension$380,318
R01 · FY2024 · HL · contact PI
Investigating the molecular mechanisms of right ventricular failure in pulmonary hypertension$380,318
R01 · FY2023 · HL · contact PI
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis$175,824
K08 · FY2023 · HL · contact PI
Investigating the molecular mechanisms of right ventricular failure in pulmonary hypertension$380,318
R01 · FY2022 · HL · contact PI
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis$175,824
K08 · FY2022 · HL · contact PI
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis$175,824
K08 · FY2021 · HL · contact PI
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis$175,824
K08 · FY2020 · HL · contact PI
Role of the Novel MicroRNA-125b in Pulmonary Hypertension Associated with Pulmonary Fibrosis$175,824
K08 · FY2019 · HL · contact PI